LSI vs MRVI
LSI (LSI) versus Maravai Lifesciences Holdings Inc (MRVI) — a side-by-side from cached financials, not a winner call.
LSI (LSI) common stock.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
LSI does not have a complete income-statement cache yet.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
MRVI currently screens at market cap $1.93B.
Not investment advice. Open the LSI and MRVI stock pages for the full models.
Not investment advice.